Previous close | 46.95 |
Open | 46.95 |
Bid | 43.75 |
Ask | 46.15 |
Strike | 42.50 |
Expiry date | 2024-01-19 |
Day's range | 46.95 - 46.95 |
Contract range | N/A |
Volume | |
Open interest | 7 |
When Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) CEO Warren Buffett buys or sells shares of a company, Wall Street and investors tend to pay close attention. Since becoming CEO in 1965, he's overseen the creation of more than $680 billion in shareholder value and delivered an average annual return of 20.1% for Berkshire's Class A (BRK.A) shareholders (himself included).
Oracle (ORCL) closed the most recent trading day at $67.04, moving -1.84% from the previous trading session.
The HIV Vaccine Trials Network, funded by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the NIH, today launched a new HIV awareness campaign and the Red Ribbon Registry with the goal of helping end HIV. Built by Oracle, the unique cloud-based registry makes it easy for anyone to volunteer to be considered for an HIV clinical study – getting us one step closer to a cure. To learn more or volunteer for an HIV clinical study visit https://www.helpendhiv.org/.